Skip to main content
Premium Trial:

Request an Annual Quote

Parse Biosciences Strikes South Korean Distribution Deal

NEW YORK — Parse Biosciences said on Monday that it has signed an agreement to commercialize its single-cell RNA sequencing kits in South Korea with Seoul-based Molecular Diagnostics Korea.

According to Parse, the deal covers its Evercode Whole Transcriptome products, as well as its Cell Fixation and Nuclei Fixation kits. Financial and other terms of the arrangement were not disclosed.

Seattle-based Parse, which raised $41.5 million in a Series B financing earlier this year, has taken steps in recent months to expand both its product offerings and its global presence, recently launching a 1 million cell whole-transcriptome kit and a "mini" 10,000-cell kit and forming product distribution alliances covering Southeast Asia and Oceania.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.